Query: NC_007963:3225306 Chromohalobacter salexigens DSM 3043, complete genome Lineage: Chromohalobacter salexigens; Chromohalobacter; Halomonadaceae; Oceanospirillales; Proteobacteria; Bacteria General Information: Chromohalobacter salexigens DSM 3043 was first isolated from a solar salt facility on Bonaire Island, Netherlands Antilles. A moderate halophile which can grow on a variety of salts. This bacterium is a moderate halophile, yet does not require high concentrations of sodium chloride. The salt requirements of this organism can be met by ions of other salts, such as potassium, rubidium, ammonium, bromide. Several plasmids have been isolated from this organism. Plasmid pMH1 contains genes for resistance to kanamycin, neomycin, and tetracycline. A smaller plasmid, pHE1, which does not code for antibiotic resistance genes, has also been isolated.
- Sequence; - BLASTP hit: hover for score (Low score = Light, High score = Dark); - hypothetical protein; - cds: hover for description
General Information: This organism was discovered in 1819 by Bizio who named the organism after the Italian physicist Serrati. It was considered a nonpathogenic organism until late in the 20th century, although pathogenicity was noted as early as 1913. Serratia marcescens is an opportunistic human pathogen that is increasingly associated with life-threatening hospital-acquired infections. It is an environmental organism that has a broad host range, and is capable of infecting vertebrates and invertebrates, as well as plants. In humans, Serratia marcescens can cause meningitis (inflammation of the membrane surrounding the brain and spinal cord), endocarditis (inflammation of heart muscle) and pyelonephritis (inflammation of the kidneys). Many strains are resistant to multiple antibiotics. Environmental isolates are noted by production of the red pigment prodigiosin.